Psylo signs research deal with Daiichi Sankyo for psychiatric therapies

psylo_news
Written By Dilara Bahceci

Psylo plans to open a new office at the B+labs incubation space in Philadelphia, Pennsylvania, US.

Dilara Bahceci
Previous

Australian startup Psylo advances depression treatment with Japanese pharma firm Daiichi Sankyo
Next

Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies